The rest of the 23 CWD-positive deer harvested by hunters during the 2024-25 hunting season were found in Allen, Hardin, ...

Colombia's health ministry yesterday declared a public health emergency owing to the circulation of yellow fever in several ...

US flu activity declined steadily again last week, with rates of influenza-like illness (ILI) dropping further and staying ...

US hospital data from 2018 through 2022 shows carbapenem-resistant Acinetobacter baumanii accounted for more than one third of all Acinetobacter nfections.

The Advisory Committee on Immunization Practices convened to make expanded vaccine recommendations amidst CDC leadership changes.

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.